Prognosys Medical Systems, established in 2004, leads India’s digital imaging equipment industry, driving innovation in medical diagnostics. Prognosys has evolved into an engineering hub, designing and manufacturing medical imaging equipment under the ProRad™ brand.
With a focus on quality, the company is based in Bengaluru, offering a range of radiology and fluoroscopy solutions for various applications. Committed to providing SMART (Safe, Modern, Affordable, Reliable, Trendy) solutions, Prognosys aims to be a respected leader in diagnostic imaging.
Key Personnel
Mr. Krishna Prasad Vajapeyam
Founder and President
Prognosys Medical Systems
Krishna Prasad Vajapeyam is an engineer from Bangalore University with a Master of Science degree from the United States. He began his illustrious business career 34 years ago and has since grown from a small distribution company in Bangalore to a globally recognised digital imaging technology company. He founded Prognosys Medical Systems in 2004 with a goal to develop technology solutions for medical imaging and digital health for point of care.
Mr. Sriram Natarajan
Chairman and CEO
Molbio Diagnostics
Sriram Natarajan, a technocrat, is the founding Director and CEO of Molbio Diagnostics Pvt. Ltd. He holds M.Sc. and M.Phil. degrees, four years of academic research experience, and 34 years of expertise developing, manufacturing, and marketing diagnostic devices and kits for global markets in both the private and government sectors. He founded Tulip group in 1989 and grew it to become the largest IVD reagent company in India and a significant player globally. He successfully exited Tulip in 2017 and founded Molbio diagnostics which focuses on taking modern diagnostic technologies to the point of care.
Dr. Chandrasekhar Nair
Director and CTO
Molbio Diagnostics
Dr. Chandrasekhar Nair heads Bigtec Labs and serves as the Chief Technical Officer for Molbio Diagnostics Pvt. Ltd. He obtained his Bachelor’s, Master’s degrees in Chemical Engineering from BITS Pilani and a PhD in Bio-MEMS from VIT. He has extensive expertise in modelling bioprocesses, scaling them up, and commercializing bio and chemical processes. Over the past decade, his primary focus has been on developing rapid, portable, high-quality, and low-cost diagnostics that bring the power of a modern laboratory to the point of care.
Journey
Prognosys was Estd in 2004. Prognosys worked with Govt of India to establish a nation-wide digital health network.
2004
Importer and distributor Canon Digital X-ray Systems (DR) enters India in association with Prognosys
2007
First local Integration of DR systems
2010
Pioneered the digitisation of x-rays (DR) across multiple state-wide networks
2012
Somerset Indus invests into Prognosys to design and manufacture a range of indigenous digital x-ray products
2015
• Prognosys products get CE & FDA Approval
• Prognosys starts exports to SE Asia & Africa
2018
• Prognosys and Molbio collaborate for end-to-end TB solutions
• WHO awards order for End-to-End Mobile E- Clinic for TB Screening Solution
2022
• Molbio Diagnostics acquires majority stake in Prognosys Medical Systems
2023
Global Footprint
